Kyntra Bio (KYNB) Restructuring Costs (2023 - 2026)
Kyntra Bio (KYNB) posted Restructuring Costs of $22000.0 for Q1 2026, up 414.29% sequentially from -$7000.0 in Q4 2025, and down 82.54% YoY from $126000.0 in Q1 2025.
Kyntra Bio (KYNB) Restructuring Costs (2023 - 2026) Analysis & Trends
Kyntra Bio has reported Restructuring Costs for 4 years, with the latest figure at $22000.0 in Q1 2026.
- Quarterly Restructuring Costs fell 82.54% year-over-year to $22000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $449000.0 (down 97.71% YoY) and the FY2025 annual result came in at $553000.0, down 97.16% from the prior year.
- Restructuring Costs advanced to $22000.0 in Q1 2026 per KYNB's latest filing, from -$7000.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $18.6 million in Q3 2024 and troughed at -$7000.0 in Q4 2025.
- A 4-year average of $4.1 million and a median of $259500.0 in 2025 frame the typical range for Restructuring Costs.
- The sharpest annual moves came in 2024 and 2025: Restructuring Costs jumped 47.18% in 2024, then plunged 100.78% in 2025.
- Over 4 years, Restructuring Costs stood at $12.6 million in 2023, then slumped by 92.86% to $900000.0 in 2024, then sank by 100.78% to -$7000.0 in 2025, then jumped by 414.29% to $22000.0 in 2026.
- According to Business Quant data, Restructuring Costs over the past three periods registered $22000.0, -$7000.0, and $41000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | Kyntra Bio | 29.87 Mn | 29.87 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | -7,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 393,000.00 |
| Mar 31, 2025 | 126,000.00 |
| Dec 31, 2024 | 900,000.00 |
| Sep 30, 2024 | 18.55 Mn |
| Sep 30, 2023 | 12.61 Mn |